Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Quality of life and comorbidity in localized malignant melanoma: results of a German population-based cohort study.

Schubert-Fritschle G, Schlesinger-Raab A, Hein R, Stolz W, Volkenandt M, Hölzel D, Engel J.

Int J Dermatol. 2013 Jun;52(6):693-704. doi: 10.1111/j.1365-4632.2011.05401.x. Epub 2013 Feb 22.

PMID:
23432215
2.

No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.

Schäfer A, Emmert S, Kruppa J, Schubert S, Tzvetkov M, Mössner R, Reich K, Berking C, Volkenandt M, Pföhler C, Schön MP, Vogt T, König IR, Reichrath J.

Arch Dermatol Res. 2012 Jul;304(5):353-61. doi: 10.1007/s00403-012-1243-3. Epub 2012 May 11.

3.

Primary cutaneous actinomycosis of the femorogluteal region: two case reports.

Varga R, Kovneristy A, Volkenandt M, Sárdy M, Ruzicka T.

Acta Derm Venereol. 2012 Jul;92(4):445-6. doi: 10.2340/00015555-1293. No abstract available.

4.

Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).

Ziefle S, Egberts F, Heinze S, Volkenandt M, Schmid-Wendtner M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Heinz A, Hauschild A, Schaefer M.

J Immunother. 2011 May;34(4):403-8. doi: 10.1097/CJI.0b013e31821b7a4b.

PMID:
21499123
5.

Analysis of predictive factors for the outcome of complete lymph node dissection in melanoma patients with metastatic sentinel lymph nodes.

Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH.

J Am Acad Dermatol. 2011 Apr;64(4):655-62; quiz 637. doi: 10.1016/j.jaad.2010.02.047.

PMID:
21315477
6.

Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.

Friebe A, Horn M, Schmidt F, Janssen G, Schmid-Wendtner MH, Volkenandt M, Hauschild A, Goldsmith CH, Schaefer M.

Psychosomatics. 2010 Nov-Dec;51(6):466-73. doi: 10.1176/appi.psy.51.6.466.

PMID:
21051677
7.

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion.

Potthoff K, Hofheinz R, Hassel JC, Volkenandt M, Lordick F, Hartmann JT, Karthaus M, Riess H, Lipp HP, Hauschild A, Trarbach T, Wollenberg A.

Ann Oncol. 2011 Mar;22(3):524-35. doi: 10.1093/annonc/mdq387. Epub 2010 Aug 13.

8.

Plantar melanoma: is the prognosis always bad?

Baumert J, Schmidt M, Kunte C, Volkenandt M, Ruzicka T, Berking C, Schmid-Wendtner MH.

Dermatol Surg. 2010 Aug;36(8):1325-7. doi: 10.1111/j.1524-4725.2010.01632.x. Epub 2010 Jun 24. No abstract available.

PMID:
20584045
9.

Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.

Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH.

Melanoma Res. 2010 Aug;20(4):330-7. doi: 10.1097/CMR.0b013e32833ba9ff.

PMID:
20526218
10.

Quality of life in localised malignant melanoma.

Schlesinger-Raab A, Schubert-Fritschle G, Hein R, Stolz W, Volkenandt M, Hölzel D, Engel J.

Ann Oncol. 2010 Dec;21(12):2428-35. doi: 10.1093/annonc/mdq255. Epub 2010 May 21.

11.

[A rare case of local relapsing oral melanoma].

Gauwerky KJ, Ehrenfeld M, Bakos RM, Volkenandt M, Ruzicka T, Berking C.

J Dtsch Dermatol Ges. 2010 Aug;8(8):614-6. doi: 10.1111/j.1610-0387.2010.07347.x. Epub 2010 Feb 15. German.

PMID:
20163505
12.

Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.

Heinze S, Egberts F, Rötzer S, Volkenandt M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Hinzpeter A, Hauschild A, Schaefer M.

J Immunother. 2010 Jan;33(1):106-14. doi: 10.1097/CJI.0b013e3181b8bdb9.

PMID:
19952950
13.

The use of high-resolution ultrasonography for preoperative detection of metastases in sentinel lymph nodes of patients with cutaneous melanoma.

Kunte C, Schuh T, Eberle JY, Baumert J, Konz B, Volkenandt M, Ruzicka T, Schmid-Wendtner MH.

Dermatol Surg. 2009 Nov;35(11):1757-65. doi: 10.1111/j.1524-4725.2009.01288.x. Epub 2009 Jul 29.

PMID:
19660025
14.

Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.

Schoof N, von Bonin F, König IR, Mössner R, Krüger U, Reich K, Berking C, Volkenandt M, Ziegler A, Böckmann L, Kuschal C, Thoms KM, Kube D, Emmert S.

Genes Immun. 2009 Sep;10(6):586-90. doi: 10.1038/gene.2009.40. Epub 2009 May 21.

PMID:
19458621
15.

Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.

Hauschild A, Weichenthal M, Rass K, Linse R, Ulrich J, Stadler R, Volkenandt M, Grabbe S, Proske U, Schadendorf D, Brockmeyer N, Vogt T, Rompel R, Kaufmann R, Kaatz M, Näher H, Mohr P, Eigentler T, Livingstone E, Garbe C.

J Clin Oncol. 2009 Jul 20;27(21):3496-502. doi: 10.1200/JCO.2008.21.3892. Epub 2009 May 11.

PMID:
19433681
16.

Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype.

Baumert J, Schmidt M, Giehl KA, Volkenandt M, Plewig G, Wendtner C, Schmid-Wendtner MH.

Melanoma Res. 2009 Feb;19(1):24-30. doi: 10.1097/CMR.0b013e32831c6fe7.

PMID:
19430403
17.

Short German guidelines: malignant melanoma.

Garbe C, Schadendorf D, Stolz W, Volkenandt M, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R, Hauschild A.

J Dtsch Dermatol Ges. 2008 May;6 Suppl 1:S9-S14. doi: 10.1111/j.1610-0387.2008.06711.x. English, German. No abstract available.

PMID:
18801142
18.

[Palliative medicine--much more than pain therapy].

Borasio GD, Volkenandt M.

MMW Fortschr Med. 2008 Feb 14;150(7):27-9. Review. German. No abstract available.

PMID:
18361144
19.

Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R.

Melanoma Res. 2008 Apr;18(2):152-60. doi: 10.1097/CMR.0b013e3282f702bf.

PMID:
18337653
20.

Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection.

Giehl KA, Müller-Sander E, Rottenkolber M, Degitz K, Volkenandt M, Berking C.

J Eur Acad Dermatol Venereol. 2008 Jun;22(6):722-8. doi: 10.1111/j.1468-3083.2008.02587.x. Epub 2008 Feb 25.

PMID:
18312326

Supplemental Content

Loading ...
Support Center